Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus
Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus
复制标题
博纳病病毒大鼠鼻内感染后病毒传播动力学及脑内几种细胞因子mRNA水平的变化
DOI:
10.1128/jvi.66.2.992-998.1992
复制
发表时间:
1992
影响因子:
5.4
通讯作者:
B. Dietzschold
中科院分区:
文献类型:
--
作者:
V. Shankar;M. Kao;A. Hamir;Hai Sheng;H. Koprowski;B. Dietzschold
We have used the reverse transcriptase-polymerase chain reaction technique to gain insight into the pathogenesis of encephalitis caused by Borna disease virus (BDV). RNA specific for BDV was first detected in the olfactory bulb of intranasally infected rats at 6 days postinfection (p.i.). At 14 days p.i., high levels of BDV RNA were found in all brain regions, and at 26 days p.i., BDV-specific RNA was also present in the eye, nasal mucosa, and facial skin. In the chronic phase of the disease, BDV RNA was identified in many peripheral organs but not in blood. Analysis of brain tissue for the presence of cytokine mRNAs revealed that the mRNA levels of interleukin-6 (IL-6), tumor necrosis factor alpha, and IL-1 alpha had increased sharply at 14 and 26 days p.i. These cytokine mRNAs reached maximum levels at the peak of inflammatory reactions and decreased drastically in the chronic phase of the disease. Although IL-2 mRNA was also found in normal brain, it was markedly increased in BDV-infected brain at 14 days p.i. Expression of gamma interferon (IFN-gamma) mRNA, which was not observed in normal rat brain, was detected at 14 days p.i. and reached a maximum level at 38 days p.i. IL-2 and IFN-gamma mRNA expression correlated with expression of CD4 and CD8 mRNAs, indicating that both CD4+ and CD8+ T lymphocytes are induced in the early stages of BDV infection. Since IFN-gamma and CD8 mRNA levels were still highly elevated in the chronic phase of Borna disease, it is likely that CD8+ T lymphocytes act to reduce inflammation and to ameliorate neurological signs during the chronic phase of infection.
登录
查看更多内容
DOI:
10.1073/pnas.84.21.7644
发表时间:
1987
影响因子:
11.1
作者:
Gorman,SD;Tourvieille,B;Parnes,JR
通讯作者:
Parnes,JR
DOI:
10.1093/infdis/163.4.862
发表时间:
1991
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Holodniy,M;Katzenstein,DA;Sengupta,S;Wang,AM;Casipit,C;Schwartz,DH;Konrad,M;Groves,E;Merigan,TC
通讯作者:
Merigan,TC
DOI:
10.1016/0090-1229(91)90124-s
发表时间:
1991-03-01
期刊:
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY
影响因子:
--
作者:
HOFMAN, FM;HINTON, DR;MERRILL, JE
通讯作者:
MERRILL, JE
DOI:
--
发表时间:
1991
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Harris,CA;Derbin,KS;Hunte-McDonough,B;Krauss,MR;Chen,KT;Smith,DM;Epstein,LB
通讯作者:
Epstein,LB
DOI:
--
发表时间:
1990
期刊:
Research publications - Association for Research in Nervous and Mental Disease
影响因子:
--
作者:
Price,RW;Brew,BJ;Rosenblum,M
通讯作者:
Rosenblum,M